Bloomberg Anywhere Remote Login Bloomberg Terminal Request a Demo

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Alchemia Ltd Shares Rise 20% on Lung Cancer Trial Update

Sept. 28 (Bloomberg) -- Alchemia Ltd. shares rose 20% in Sydney trading after the company said its HA-Irinotecan product showed promising results in its first two small cell lung cancer patients reporting substantial shinkage of their tumors after 10 days.

Link to Company News:{ACL AU <Equity> CN <GO>}

To contact the editor responsible for this story: Rebecca Evans at revans6@bloomberg.net

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.